stoxline Quote Chart Rank Option Currency Glossary
  
HEXO Corp. (HEXO)
0.71  0.017 (2.45%)    06-22 16:00
Open: 0.6722
High: 0.71
Volume: 298,445
  
Pre. Close: 0.693
Low: 0.66
Market Cap: 31(M)
Technical analysis
2023-07-07 4:46:22 PM
Short term     
Mid term     
Targets 6-month :  1.39 1-year :  1.77
Resists First :  1.19 Second :  1.51
Pivot price 0.83
Supports First :  0.66 Second :  0.54
MAs MA(5) :  0.72 MA(20) :  0.89
MA(100) :  1.31 MA(250) :  1.97
MACD MACD :  -0.2 Signal :  -0.2
%K %D K(14,3) :  7.6 D(3) :  5.9
RSI RSI(14): 25.8
52-week High :  3.83 Low :  0.66
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ HEXO ] has closed above bottom band by 17.9%. Bollinger Bands are 13.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 0.71 - 0.72 0.72 - 0.72
Low: 0.65 - 0.65 0.65 - 0.66
Close: 0.7 - 0.71 0.71 - 0.72
Company Description

HEXO Corp., through its subsidiaries, produces, markets, and sells cannabis in Canada. The company offers its adult-use and medical products under the HEXO brand name. It also provides cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brands; and cannabis products under UP Cannabis, Original Stash, and Up brand names. HEXO Corp. has a strategic alliance with Tilray Brands, Inc. The company was formerly known as The Hydropothecary Corporation and changed its name to HEXO Corp. in August 2018. HEXO Corp. was founded in 2013 and is headquartered in Gatineau, Canada.

Headline News

Fri, 10 May 2024
HEXO (HEXO) Reports Q1 Loss, Misses Revenue Estimates - Yahoo News UK

Mon, 02 Oct 2023
MediPharm Labs Settles an Outstanding Claim for $9M - PR Newswire

Mon, 02 Oct 2023
Tilray to pay MediPharm CA$9M package related to Hexo cannabis supply dispute - Marijuana Business Daily

Mon, 26 Jun 2023
Tilray Brands Completes Accretive Acquisition of HEXO Corp. Leading the Next Evolution of Canadian Cannabis ... - Technical420

Mon, 26 Jun 2023
Tilray Closes Acquisition of Hexo Corp To Create 'Largest Canadian Cannabis Company by Revenue' - Business of Cannabis -

Fri, 23 Jun 2023
Marijuana company Tilray closes Hexo acquisition, eyes cost savings - Marijuana Business Daily

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Shares Out 44 (M)
Shares Float 38 (M)
Held by Insiders 3 (%)
Held by Institutions 7.5 (%)
Shares Short 972 (K)
Shares Short P.Month 1,130 (K)
Stock Financials
EPS -1.52
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 5.88
Profit Margin -203.3 %
Operating Margin -115.4 %
Return on Assets (ttm) -14.3 %
Return on Equity (ttm) -83.5 %
Qtrly Rev. Growth -54.3 %
Gross Profit (p.s.) -1.72
Sales Per Share 3.36
EBITDA (p.s.) -3.25
Qtrly Earnings Growth 0 %
Operating Cash Flow -48 (M)
Levered Free Cash Flow 168 (M)
Stock Valuations
PE Ratio -0.47
PEG Ratio 0
Price to Book value 0.12
Price to Sales 0.21
Price to Cash Flow -0.65
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android